Turning Cancer Patients and Caregivers Into Informed Decision- Makers
Hi, my name is David Emerson, and I have been living with an incurable cancer called Multiple Myeloma since 1994. I started PeopleBeatingCancer.org because I believe that there is a problem with cancer care today. Cancer patients and caregivers are asked to make huge decisions about their health-- often while woefully uninformed, and under an extreme time crunch. How many of you are here because you were given 24 hours to approve your chemotherapy regimen?
Let me be clear: knowledge is power. The more you know, the better decisions you'll make for your care. Yes, I said YOU. You are in control. This website and the non-profit organization that supports it are dedicated to helping cancer survivors and caregivers become informed, educated decision-makers about their treatment. All information found on this site is evidence-based with the studies cited, and actionable-- you can get started using the protocols right away.
Welcome!
Check out our latest blog posts:
C-B-D Becomes F.D.A. Approved AKA Mainstream?
"If the agency (F.D.A.) follows the recommendation, as is expected, the drug would be the first cannabis-derived prescription medicine available[...]
Lisa’s Story-Leukemia Diagnosis of “Not Necessarily”
Does this mean I’m going to die?” Lisa asked innocently to Dr. Nantel, the hematologist at the Vancouver General Hospital.[...]
Intraarterial Chemotherapy for Retinoblastoma-Pros and Cons
Recent reports have raised some concerns about the risk of ocular vasculopathy, radiation-related toxicity, and the potential for metastatic disease[...]
Cardiovascular Events in Multiple Myeloma Therapy
"An analysis of past studies shows 18 percent of multiple myeloma patients receiving carfilzomib experience cardiovascular adverse events (CVAE) such[...]
"In patients receiving therapy for relapsed multiple myeloma, heart failure, angina, and other cardiovascular adverse events occurred more frequently with[...]
Slow/Stop SMM’s March Toward Full-Blown Multiple Myeloma
"Hyperdiploid-myeloma is associated with male sex, kappa immunoglobulin subtype, symptomatic bone disease and better survival compared to nonhyperdiploid-MM Hi David-I[...]